Mit Magzter GOLD unbegrenztes Potenzial nutzen
Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur
Versuchen GOLD - Frei
Uber pumps in ₹3,000 cr amid Rapido rivalry
Mint Chennai
|February 26, 2026
Queries sent to Rapido, Uber and Ola remained unanswered till press time.
-
Back-to-back fund infusions from the American company in India came after the company saw its revenue stagnate at ₹3,849 crore in FY25 with only 2% year-on-year growth, compared to a 44% growth in revenue for Rapido at ₹934 crore, albeit on a lower base.
On the profit front, too, Rapido’s losses decreased in FY25 even as Uber’s losses multiplied.
Rapido, which is eyeing an initial public offering, saw its losses shrink from ₹371 crore in FY24 to ₹258 crore in FY25, according to data from MoCA.
Diese Geschichte stammt aus der February 26, 2026-Ausgabe von Mint Chennai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Chennai
Mint Chennai
Barrier-free tolling runs into a Chinese camera security bump
Commuters looking to zoom past toll plazas on India's 146,560 km highway network will have to wait longer.
1 min
February 26, 2026
Mint Chennai
A new grammar to challenge Tamil film
Members of the Problematic Family, which premiered at the Berlinale, is a striking, experimental debut film from R. Gowtham
3 mins
February 26, 2026
Mint Chennai
AUROBINDO PHARMA TAKES A PENICILLIN SHOT
The company has made a ₹2,500 crore bet to rebuild its antibiotic backbone. Will it work?
6 mins
February 26, 2026
Mint Chennai
Digital rupee pilot for food subsidy
In a significant shift in the way food subsidies are delivered, the government will launch a central bank digital currency (CBDC)-based pilot under the Pradhan Mantri Garib Kalyan Anna Yojana (PMGKAY) in Puducherry on 26 February.
1 min
February 26, 2026
Mint Chennai
DRL's obesity jab may launch in March
Dr. Reddy's Laboratories (DRL) is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with the matter as well as images reviewed by Reuters.
1 min
February 26, 2026
Mint Chennai
Uranium supply deal likely during Carney’s India visit
Cameco CEO Tim Gitzel to be part of the business delegation accompanying Canadian PM
2 mins
February 26, 2026
Mint Chennai
Warner interested in Paramount offer
Warner Bros Discovery Inc. said a new $31-a-share buyout offer from Paramount Skydance Corp. could lead to a better deal than its existing agreement with Netflix Inc., kicking off another potential round of bidding for the famed Hollywood studio.
1 mins
February 26, 2026
Mint Chennai
Hype and havoc shroud Al's impact on IT firms
Is investor anxiety over the business models of IT service companies being rendered obsolete by AI overblown? The truth lies between an apocalypse and AI-impact denial. Here's why
2 mins
February 26, 2026
Mint Chennai
Zydus plans obesity jab in pens after semaglutide patent ends
Ahmedabad-based drugmaker Zydus Lifesciences plans to launch its semaglutide injection brands upon patent expiry of the drug in India.
1 mins
February 26, 2026
Mint Chennai
CHASING 12% EQUITY RETURNS? LONG-TERM INVESTING ISN'T JUST ABOUT A NUMBER
Most investors enter equity mutual funds expecting an annual average return of about 12%.
3 mins
February 26, 2026
Listen
Translate
Change font size